Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

In vitro human skin concentrations following topical application of 2% tranexamic acid in co-enhancer cream and branded cream formulations.

Ng SP, Marcant M, Davis AF.

J Cosmet Dermatol. 2020 Jan 21. doi: 10.1111/jocd.13301. [Epub ahead of print]

PMID:
31961048
2.

Topic choice contributes to the lower rate of NIH awards to African-American/black scientists.

Hoppe TA, Litovitz A, Willis KA, Meseroll RA, Perkins MJ, Hutchins BI, Davis AF, Lauer MS, Valantine HA, Anderson JM, Santangelo GM.

Sci Adv. 2019 Oct 9;5(10):eaaw7238. doi: 10.1126/sciadv.aaw7238. eCollection 2019 Oct.

3.

Cellular fatty acid level regulates the effect of tolylfluanid on mitochondrial dysfunction and insulin sensitivity in C2C12 skeletal myotubes.

Davis AF, Thomas AA, Shorter KS, Brown SL, Baumgarner BL.

Biochem Biophys Res Commun. 2018 Oct 28;505(2):392-398. doi: 10.1016/j.bbrc.2018.09.131. Epub 2018 Sep 24.

PMID:
30262144
4.

Sex/gender disparities and women's eye health.

Clayton JA, Davis AF.

Curr Eye Res. 2015 Feb;40(2):102-9. doi: 10.3109/02713683.2014.986333. Epub 2014 Dec 30. Review.

PMID:
25548854
5.

Residents' willingness-to-pay for attributes of rural health care facilities.

Allen JE 4th, Davis AF, Hu W, Owusu-Amankwah E.

J Rural Health. 2015 Winter;31(1):7-18. doi: 10.1111/jrh.12080. Epub 2014 Jul 15.

PMID:
25040781
6.

Are all aciclovir cream formulations bioequivalent?

Trottet L, Owen H, Holme P, Heylings J, Collin IP, Breen AP, Siyad MN, Nandra RS, Davis AF.

Int J Pharm. 2005 Nov 4;304(1-2):63-71. Epub 2005 Sep 1.

PMID:
16139970
7.

Pharmacogenetics research network and knowledge base fourth scientific meeting.

Davis AF, Long RM.

Pharmacogenomics J. 2004;4(6):359-61. No abstract available.

PMID:
15467780
8.

Effect of finite doses of propylene glycol on enhancement of in vitro percutaneous permeation of loperamide hydrochloride.

Trottet L, Merly C, Mirza M, Hadgraft J, Davis AF.

Int J Pharm. 2004 Apr 15;274(1-2):213-9.

PMID:
15072797
9.

Penciclovir solubility in Eudragit films: a comparison of X-ray, thermal, microscopic and release rate techniques.

Ahmed A, Barry BW, Williams AC, Davis AF.

J Pharm Biomed Anal. 2004 Mar 10;34(5):945-56.

PMID:
15019028
10.

Pharmacogenetics Research Network and Knowledge Base third scientific meeting.

Davis AF, Long RM.

Pharmacogenetics. 2003 Jul;13(7):437-40. No abstract available.

PMID:
12835619
11.

Pharmacogenetics research network and knowledge base second scientific meeting.

Davis AF, Long RM.

Pharmacogenomics J. 2002;2(5):293-6. No abstract available.

12.

UV-spectrophotometry study of membrane transport processes with a novel diffusion cell.

Kierstan KT, Beezer AE, Mitchell JC, Hadgraft J, Raghavan SL, Davis AF.

Int J Pharm. 2001 Oct 23;229(1-2):87-94.

PMID:
11604261
13.

The stability of benzoyl peroxide by isothermal microcalorimetry.

Zaman F, Beezer AE, Mitchell JC, Clarkson Q, Elliot J, Davis AF, Willson RJ.

Int J Pharm. 2001 Oct 4;227(1-2):133-7.

PMID:
11564547
14.

The stability of benzoyl peroxide formulations determined from isothermal microcalorimetric studies.

Zaman F, Beezer AE, Mitchell JC, Clarkson Q, Elliot J, Nisbet M, Davis AF.

Int J Pharm. 2001 Aug 28;225(1-2):135-43.

PMID:
11489561
15.

Membrane transport of hydrocortisone acetate from supersaturated solutions; the role of polymers.

Raghavan SL, Kiepfer B, Davis AF, Kazarian SG, Hadgraft J.

Int J Pharm. 2001 Jun 19;221(1-2):95-105.

PMID:
11397571
16.

Crystallization of hydrocortisone acetate: influence of polymers.

Raghavan SL, Trividic A, Davis AF, Hadgraft J.

Int J Pharm. 2001 Jan 16;212(2):213-21.

PMID:
11165079
17.

Effect of cellulose polymers on supersaturation and in vitro membrane transport of hydrocortisone acetate.

Raghavan SL, Trividic A, Davis AF, Hadgraft J.

Int J Pharm. 2000 Jan 5;193(2):231-7.

PMID:
10606787
18.

Kinetics of synaptotagmin responses to Ca2+ and assembly with the core SNARE complex onto membranes.

Davis AF, Bai J, Fasshauer D, Wolowick MJ, Lewis JL, Chapman ER.

Neuron. 1999 Oct;24(2):363-76. Erratum in: Neuron 1999 Dec;24(4):1049.

19.

Mapping the agonist binding site of the GABAA receptor: evidence for a beta-strand.

Boileau AJ, Evers AR, Davis AF, Czajkowski C.

J Neurosci. 1999 Jun 15;19(12):4847-54.

20.

Delineation of the oligomerization, AP-2 binding, and synprint binding region of the C2B domain of synaptotagmin.

Chapman ER, Desai RC, Davis AF, Tornehl CK.

J Biol Chem. 1998 Dec 4;273(49):32966-72.

21.

Direct interaction of a Ca2+-binding loop of synaptotagmin with lipid bilayers.

Chapman ER, Davis AF.

J Biol Chem. 1998 May 29;273(22):13995-4001.

22.

Effects of TPA, bryostatin 1, and retinoic acid on PO-B, AP-1, and AP-2 DNA binding during HL-60 differentiation.

Davis AF, Meighan-Mantha RL, Riegel AT.

J Cell Biochem. 1997 Jun 1;65(3):308-24.

PMID:
9138088
23.
24.
26.

Distribution of RNase MRP RNA during Xenopus laevis oogenesis.

Davis AF, Jeong-Yu S, Clayton DA.

Mol Reprod Dev. 1995 Nov;42(3):359-68.

PMID:
8579850
27.

Group aversion by imaginal, vicarious and shared recipient-observer shocks.

Rosenthal TL, Linehan KS, Kelley JE, Rosenthal RH, Theobald DE, Davis AF.

Behav Res Ther. 1978;16(6):421-7. No abstract available.

PMID:
736875
28.

A case of calcified gall bladder.

DAVIS AF.

S Afr Med J. 1953 Jul 4;27(27):567. No abstract available.

PMID:
13076735

Supplemental Content

Loading ...
Support Center